We provide professional support in General Nuclear Medicine.
Nuclear medicine is a branch of medical imaging, which
uses small amounts of radioactive materials in order to diagnose, determine the
severity and treat various diseases, including many kinds of cancer, cardiac
disease and gastrointestinal, endocrine and neurological disorders as well as
other anomalies in body. As the nuclear medicine operations can determine
the location of molecular activity inside body, it provides a potential to
determine a disease in its early phases stages and define the first response to
the interventions for medical purpose.
Nuclear medicine imaging operations do not have an
interventional characteristic, they are mostly painless medical tests which
help physicians to diagnose medical problems and evaluate them, except for the
intravenous injections. These imaging scans use the radioactive materials,
named radiopharmaceutical or radiotracer materials.
Radiotracer materials are either injected to body or
swallowed or taken into the respiratory system in the form of gas, depending on
the type of nuclear medicine examination, and finally they accumulate in an
organ or an examined area of body. Radioactive emissions, created by
radiotracer materials, are detected with a special camera or imaging device
which create images and provide molecular information.
In many centers, nuclear medicine images can be put on
the images of computerized tomography (CT) or magnetic resonance imaging (MRI)
or combined with these images by the means of an application, known as image
fusion or co-record. These images allow obtaining more accurate information and
make more sensitive diagnosis by allowing the correlation and interpretation of
information that is obtained through two different examinations through one
image. Additionally, today, manufacturers produce single-photon emission
computed tomography / computerized tomography (SPECT/BT) and positron emission
tomography / computerized tomography (PET/BT) units which can provide both
imaging techniques at the same time. Even if PET/MRI cannot be easily used yet,
it is a newly developed imaging technology.
Physicians use the radionuclide imaging procedures in
order to see the structure and function of a body, tissue, bone or system in
Phasing cancer by determining the existence or spread of
cancer in various parts of body
Determination of the sentinel lymph nodes before
operation in the patients, suffering from breast cancer or skin and soft tissue
Evaluation of response to treatment.
Diagnosis of the recurrence of cancer.
Diagnosis of rare tumors in pancreas and adrenals glands.
Analysis of blood flow and function of a natural and transplanted kidney.
Diagnosis of urethral stricture
Evaluation of renal artery-related hypertension.
Evaluation of renal infections in terms of scarred tissue
Diagnosis and following-up urinary reflux
Examination of anomalies in esophagus, such as esophageal
reflux or motility disorders
Evaluation of nasolacrimal ducts’ openings
Evaluation of ventricular shunts’ openings in brain
Examination of congenital heart disease in terms of shunt
and pulmonary blood flow
The radioactive iodine therapy (I-131), used for the
treatment of some reasons of hyperparathyroidism (hyperactive thyroid gland,
for example, Graves’ disease) and thyroid cancer
The radioactive antibodies, used for the treatment of
some kinds of lymphoma (lymphatic system cancer)
The radioactive phosphor (P-32), used for the treatment
of specific blood disorders.
The radioactive materials, used for the treatment of
painful tumor metastasis in bones.
I-131 MIBG (radioactive iodine marked with
metaiodobenzylguanidine), used for the treatment of adrenal gland tumors and
adrenal glands in children / nervous tissue tumors (radioactive iodine marked